Status:
COMPLETED
Target ADHD Executive Working Memory Study
Lead Sponsor:
Hartford Hospital
Conditions:
ADHD
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
This study will assess whether or not a novel executive working memory training intervention for Attention-Deficit/Hyperactivity Disorder can engage frontoparietal brain network treatment targets and ...
Detailed Description
This proposal seeks support for a 2-year milestone-driven R61 initial test of target engagement in n=62 ADHD diagnosed adolescents randomized to a 'sham training' placebo or to train 4 times each week...
Eligibility Criteria
Inclusion
- Diagnosis of ADHD
- English speaking
- Right-handed
- \>5th grade reading level
- \>80 IQ level
Exclusion
- Braces, metal or implant devices
- Brain abnormality, neurological disorder
- TBI or loss of consciousness\>30 minutes
- Diagnosis of Psychosis, Bipolar Disorder, ASD, PTSD, OCD, SUD, Tourette's Disorder
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 19 2023
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04795674
Start Date
November 1 2021
End Date
March 19 2023
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Living/Hartford Hospital
Hartford, Connecticut, United States, 06106